Leading a group of senior project toxicologists in Neuroscience and Tropical Disease indications, marketed products across all indications and impurity assessments/qualifications. Overseeing non-clinical toxicology safety assessments for drug candidate profiling from target identification to post-marketing for small molecules, ASO, biologics and gene replacement therapies. Extensive experience in Health Authority negotiations at all stages of drug development. EUROTOX-certified toxicologist since 1999. Member of IMI SafeSciMET (European Training and Education initiative) Executive Committee. 50+ journal publications (25 as first/senior author). Specialties: Integrated non-clinical - clinical safety assessment; genetic toxicology; neuroscience indications; impurity assessment. Extensive experience in Health Authority negotiations at all stages of drug development.Chair of EFPIA Preclinical Development Expert Group 50+ journal publications (25 as first/senior author), 8 book chapters.Specialties: Integrated non-clinical - clinical safety assessment; genetic toxicology; neuroscience indications; impurity assessment